fig1

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Figure 1. Diagnostic plots assessing assumptions of the multivariable linear regression models for CAP values. (A) Residuals closely follow the diagonal line, supporting normality in the normal-weight model; (B) Residuals approximate the diagonal line, validating normality in the overweight model; (C) Histogram showing a near-normal distribution of residuals for the normal-weight model; (D) Residuals are approximately symmetrical and unimodal in the overweight model, supporting normality; (E) Residuals are randomly dispersed around zero, indicating homoscedasticity for the normal-weight model; (F) Random scatter of residuals confirms homoscedasticity in the overweight model. Collectively, plots (A-F) validate key regression assumptions - normality, homoscedasticity, and independence - for both BMI subgroups. Durbin-Watson statistics (2.01 and 2.02) and VIF values < 5 confirm absence of autocorrelation and multicollinearity, respectively. CAP: Controlled attenuation parameter; BMI: body mass index; VIF: variance inflation factor.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/